MapLight Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MapLight Therapeutics, Inc. (MPLT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 9.11 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- MapLight Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 9.59M shares, a 44.47% decline year-over-year.
- MapLight Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 17.27M shares.
- MapLight Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 9.16M shares, a 47.04% decline from fiscal 2024.
- MapLight Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 17.30M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 9.11M shares 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 9.59M shares 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 9.16M shares 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 32.56M shares 10-Q · filed 2025-12-04 | |||
| 2025-06-30 | 17.29M shares 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | 17.27M shares 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | 17.30M shares 10-K · filed 2026-03-26 | |||
| 2024-09-30 | 17.29M shares 10-Q · filed 2025-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |